Comprehensive Population Screening Market Forecast 2025-2034: Growth Trends and Strategic Shifts

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Population Screening Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of population screening has experienced robust growth. It is predicted to expand from a value of $29.31 billion in 2024 to $31.46 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The historically observed growth can be credited to initiatives for disease prevention, governmental health strategies, the escalation in healthcare costs, and heightened awareness of diseases.

Population Screening Market Size Forecast: What's the Projected Valuation by 2029?
Strong expansion is anticipated in the population screening market over the coming years, with its value expected to touch $41.51 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.2%. This expected growth during the forecast period can be attributed to the inclination towards personalized medicine, the rising numbers of elderly people and chronic diseases, the integration of artificial intelligence and data analytics, and the broadening accessibility of screening. The dominant trends for the forecast period encompass progress in medical technology, genomics and precision screening, telehealth and remote screening, panels for screening multiple diseases, and issues of health equity and accessibility.

View the full report here:
https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

What Are the Drivers Transforming the Population Screening Market?
The surging instances of cancer are anticipated to fuel the expansion of the population screening market in the future. Cancer is a health disorder where certain cells in the human organism grow uncontrollably and metastasize to other body parts. Early detection of cancer through population screening can result in more effective treatment and improved survival rates. For example, as reported by the American Cancer Society Inc., a voluntary health organization in the US, in January 2023, cancer deaths reached 608,570 in 2022, witnessing a slight increase from 606,520 deaths in 2021 along with an estimated 1.9 million fresh cancer instances. Hence, the increasing frequency of cancer is the key driving force behind the upward trajectory of the population screening market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

What Long-Term Trends Will Define the Future of the Population Screening Market?
Key players in the population screening market are developing innovative services like newborn mass screening to bolster early detection and enhance the health outcomes of infants. Newborn mass screening is a healthcare program that tests newborns shortly after birth for a variety of genetic, metabolic, hormonal, and functional disorders. These conditions may not be immediately obvious at birth but could result in severe health issues if not treated. For instance, in May 2024, Shimadzu Techno-Research Inc., a subsidiary of Japan-based precision instruments manufacturer Shimadzu Corporation, introduced a new contract service that facilitates polymerase chain reaction (PCR) testing for extended newborn mass screening. This service will screen for disorders such as severe combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA), which currently affect a small percentage of newborns, necessitating immediate intervention upon diagnosis.

Which Segments in the Population Screening Market Offer the Most Profit Potential?
The population screening market covered in this report is segmented -

1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation
2) By Gender: Male, Female
3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above
4) By Business: Hospitals, Research Institutes, Diagnostic Labs

Subsegments:
1) By Hardware Equipment: Diagnostic Devices, Sample Collection Devices, Imaging Equipment
2) By Testing Or Lab: Laboratory Testing Kits, Point-Of-Care Testing, Blood And Urine Testing Services
3) By Analytics Or Interpretation: Software Solutions For Data Analysis, Interpretation Services, Reporting Tools

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12587&type=smp

Which Firms Dominate the Population Screening Market by Market Share and Revenue in 2025?
Major companies operating in the population screening market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., Evoq Technologies LLC, LabPLUS

Which Regions Offer the Highest Growth Potential in the Population Screening Market?
North America was the largest region in the population screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12587

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.